Chapter 5 – Health Care Costs
The drivers of health care costs, federal spending, consumer spending, and industry consolidation.
Click on an event to access its materials, such as videos, transcripts, and presentations.
COVID-19 Webinar Series Session 16 – The Changing Landscape of Primary Care
During this webinar, panelists discussed the recent evolution of our primary care system and outlined policy levers to bolster our nation’s primary care infrastructure.
Protected: 2020 Health Policy Academy for Staff
There is no excerpt because this is a protected post.
Perspectives on Health Policy from the Director of the Domestic Policy Council
During this on-the-record briefing for reporters, Joe Grogan, Assistant to the President and Director of the Domestic Policy Council provided opening remarks and responded to questions from reporters. The question and answer period was moderated by William Pierce, Senior Director, APCO Worldwide.
Modernizing Medicare Part D
During this congressional lunch briefing, analysts will outline the mechanisms of the Medicare Part D program under current law and discuss the potential implications of reforms put forward by Congress and the administration.
Unpacking Policy Options to Promote Prescription Drug Affordability
During this briefing, panelists will discuss components of policy proposals under consideration and explore evidence about their implications for the health care system.
Fall 2019 Legislative and Regulatory Outlook
During this webinar, analysts discussed the outstanding legislative and regulatory activities that Congress and the administration are likely to pursue before the end of the year.
Legislative Outlook – What’s Ahead for Comparative Effectiveness Research?
This webinar outlined the various PCORI reauthorization bills and amendments that have been discussed by House and Senate committees to date. Our panel of experts explored some of the critical questions facing congressional staff and discussed potential next steps in the legislative process.
Balancing the Bills – Policy Solutions to Address Surprise Billing
During this briefing, expert panelists discussed considerations for policy options to protect consumers from surprise medical bills.
Protected: Deep Dive: Coverage and Affordability in the Private Insurance Market
There is no excerpt because this is a protected post.
Basics of Biosimilars
During this briefing, panelists explained the mechanisms of biologic drugs, explore the impact of current regulations on the uptake of biosimilars, and discuss considerations for the biosimilars market in the United States.
Understanding the Role of Rebates in Prescription Drug Pricing
The audience will come away with a better understanding of the origins of the rebate system, the actors responsible for negotiation, and the impact of rebates on prescription drug prices.
Congressional Briefing on Health Care Costs in America
This congressional briefing explored the differences between “price” and “cost” in our current system and the potential policy options that address these discrepancies.
Summit on Health Care Costs in America
The conversation on health care costs in America is decades old, yet progress has been elusive. Terms like sustainability, affordability, and value are set forward as goals, but perspectives on how to achieve them vary widely. Speakers and panelists will provide insights on current and projected health care cost trends, what different stakeholders hope to achieve, and new approaches to consider.
Competition and Consolidation: Understanding Recent Trends in the Health Care Market
This is the first webinar, part of the Beyond the Beltway: Health Webinars for Journalists series, focused on the implications and tradeoffs of the recent trends in the health care market. Panelists helped define the basics of market concentration and competition, how experts measure the effects on different areas of the market, and how regulators approach assessing partnership proposals.
Navigating Next Steps on Payment Reform
This briefing provided an update on the overall state of play with payment reform, and the effort to move away from fee for service and toward value-based payment. Panelists discussed the interplay between the public and private sectors, and, given likely future directions for the CMS Center for Medicare and Medicaid Innovation, highlighted areas where the private sector may be best positioned to lead. Panelists shared what this means for future policy options and needs.
Prescription Drug Affordability & Innovation: Policy Options & Stakeholder Views
This Alliance for Health Policy briefing discussed current issues in prescription drug affordability and innovation, focusing on potential policy and private-sector approaches to this complex issue.
Coordinated Care and Beyond: The Future of Integrated Care for Complex Chronic Conditions: What’s Working, What’s Not?
This is the final of three panels from our Future of Chronic Care Summit.
Coordinated Care and Beyond: Coverage and Chronic Care
This is the second of three panels from our Future of Chronic Care Summit.
Coordinated Care and Beyond: Future Trends in Chronic Care
This is the first of three panels from our Future of Chronic Care Summit.
Coordinated Care and Beyond: The Future of Chronic Care
This half-day summit examined how to improve care for patients with complex, chronic conditions.
Medicare and Prescription Drug Prices
This briefing featured presentations by our experts highlighting the trends in Medicare regarding prescription drug pricing, and panelists discussed an array of policy options to align drug prices with value through alternative payment models.
Assessing Innovations in Medicaid
Medicaid is testing numerous new alternative payment and delivery system models to enhance the coordination of the health care services provided to millions of low-income Americans. This briefing examined the range of Medicaid’s efforts to improve care and promote value, including integrating health with non-clinical and behavioral services, creating managed care organizations, and instituting regional care collaborative organizations. Our panel also addressed Medicaid’s role in managing emerging issues such as the opioid epidemic and the spread of the Zika virus.